← FDA Drug Approvals (Drugs@FDA)
EPTIFIBATIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HYBIO · Approved 2020-03-20
Drug application
- FDA Application #
ANDA207864- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EPTIFIBATIDE
- Generic name
- Eptifibatide
- Active ingredients
- EPTIFIBATIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- HYBIO
- First approval
- 2020-03-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown